A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.
暂无分享,去创建一个
Stephen Neidle | S. Neidle | L. Kèlland | Christopher M Incles | C. Schultes | H. Kempski | H. Koehler | Helena Kempski | Christoph M Schultes | Lloyd R Kelland | Heike Koehler | L. Kelland
[1] L. Elmore,et al. Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction* , 2002, The Journal of Biological Chemistry.
[2] B. Gilchrest,et al. Evidence that exposure of the telomere 3′ overhang sequence induces senescence , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] Jiayuh Lin,et al. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3 , 2002, Oncogene.
[4] James M. Morrell,et al. Trisubstituted acridine derivatives as potent and selective telomerase inhibitors. , 2003, Journal of medicinal chemistry.
[5] John M Sedivy,et al. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.
[6] C. Harley,et al. A novel telomerase template antagonist (GRN163) as a potential anticancer agent. , 2003, Cancer research.
[7] J. Griffith,et al. Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.
[8] N. Carter,et al. A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.
[9] J. Mergny,et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] Stephen Neidle,et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Shay,et al. Telomerase: a target for cancer therapeutics. , 2002, Cancer cell.
[12] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[13] D. Corey,et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Neidle,et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.
[15] W. Hahn,et al. Inhibition of telomerase limits the growth of human cancer cells , 1999, Nature Medicine.
[16] Margaret A. Strong,et al. The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.
[17] T. Lange,et al. DNA Damage Foci at Dysfunctional Telomeres , 2003, Current Biology.
[18] S. Neidle,et al. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. , 2002, Molecular pharmacology.
[19] Masashi Narita,et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.
[20] K. Anderson,et al. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. , 2003, Molecular cancer therapeutics.
[21] Jing-Jer Lin,et al. Exposure of Single-stranded Telomeric DNA Causes G2/M Cell Cycle Arrest in Saccharomyces cerevisiae * , 2003, The Journal of Biological Chemistry.
[22] S. Joel,et al. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. , 2002, Cancer research.
[23] Stephen Neidle,et al. Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.